You are here: Industry Insights > COVID-19

News List

VSY Biotech Develops TR-C 19 Candidate to Treat COVID-19 contractpharma
May 18, 2020
Studies have shown that TR-C 19 can neutralize the virus isolated under lab conditions, clinical trials are underway.
Exvastat wins 3.6m euro grant for COVID-19 trial pharmatimes
May 15, 2020
Privately-held biopharma Exvastat (Ireland) Ltd has won a 3.6 million euro grant from the Innovative Medicines Initiative following its call for developers to repurpose imatinib for the treatment of Acute Respiratory Distress Syndrome (ARDS) induced by CO
FDA Authorizes First Antigen Test for Rapid Detection of COVID-19 americanpharmaceuticalreview
May 15, 2020
Statement from: Stephen M. Hahn, M.D. and Jeff Shuren, M.D., director of FDA’s Center for Devices and Radiological Health.
Mylan partners with Gilead to manufacture remdesivir, potential COVID-19 treatment europeanpharmaceuticalreview
May 15, 2020
According to a new agreement between Mylan and Gilead, the former has the rights to manufacture and distribute remdesivir in 127 countries, a drug being tested to combat COVID-19.
Doubt cast over Avigan (favipiravir) and DAS181 potential to fight COVID-19 europeanpharmaceuticalreview
May 15, 2020
A new report has highlighted that the early successes of Avigan (favipiravir) and DAS181 do not guarantee their efficacy against COVID-19.
US likely to get first access to Sanofi’s Covid-19 vaccine candidate pharmaceutical-technology
May 15, 2020
French pharmaceutical giant Sanofi CEO Paul Hudson has said that the US will likely have first access to its Covid-19 vaccine if it succeeds.
NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug expresspharma
May 15, 2020
In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown better viral inhibition ability than Remdesivir, Fevipiravir, Hydroxychloroquine, Lopinavir/Ritonavir etc.
Coronavirus vaccine possible in about a year, says EU agency expresspharma
May 15, 2020
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so beginning of 2021," said Marco Cavaleri, head of vaccines, European Medicines Agency.
Health groups ask India to rescind Gilead’s patents for COVID-19 drug remdesivir expresspharma
May 15, 2020
Gilead’s three patents in India for remdesivir stem from 2009 when the drug was in development to treat Ebola.
Sanofi says its COVID-19 vaccine will available in all countries expresspharma
May 15, 2020
The statement comes after the French government took objection to Sanofi CEO’s comment that the US will get first access to the company’s vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page